Plain-English translation of NCT07588854 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to know if a new ultrasound technique called EUS-SWQ can accurately measure how much scarring has built up in your liver. This study compares the new ultrasound method to a traditional liver biopsy (a small tissue sample taken from your liver) and to another existing imaging test, to see which works best for detecting and grading liver scarring.
Liver scarring (fibrosis) is a serious problem in chronic liver disease, but current methods to detect it can be uncomfortable or inconvenient. Researchers hope this new ultrasound technique could become a faster, safer, and more reliable way to monitor liver damage without needing tissue samples.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for testing that includes the new ultrasound technique (EUS-SWQ), a standard ultrasound test called FibroScan, and a liver biopsy — all of which your doctor has already recommended for your care. The study involves no experimental drugs or devices; researchers are simply comparing how well these existing tests measure liver scarring. You will be monitored for any discomfort or side effects during and after the procedures.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China